NEW YORK (TheStreet) -- Welcome to Don Dion's Daily ETF Winners and Losers. Be sure to stop by each day to get a feel of who's winning and who's losing when it comes to ETFs.

Winners

PowerShares DB Base Metals ETF

(DBB) - Get Report

2.4%

Base metals are heading higher today. While trading is rocky, today's better- than-expected jobless numbers appear to be instilling some confidence in investors. Base metals do well in times of market optimism.

Copper, in particular, is seeing strength today. The

iPath Dow Jones UBS Copper Total Return Subindex ETN

(JJC) - Get Report

is up 2%.

Global X Silver Miners ETF

(SIL) - Get Report

1.8%

Silver prices are gaining today, powering the silver miner ETF to its second consecutive day of strong gains.

Silver is not the only precious metal seeing a jump today

. ETFS Physical Palladium Shares

(PALL) - Get Report

, which tracks the movements in the palladium market, is another fund moving higher today.

iShares MSCI Italy Index Fund (EWI) - Get Report

0.7%

The most troubled members of the European Union are scoring gains today. Italy's markets in particular are jumping, helping the fund recover some of the ground it has lost throughout the month of August.

Although it is structured to expose investors to the broad Italian markets, EWI is heavily reliant on the performance of its top three positions:

ENI

(E) - Get Report

, Unicredit, and Enel. Together, these companies account for over 40% of the fund's total portfolio.

Losers

United States Natural Gas Fund

(UNG) - Get Report

-1.8%

Natural gas prices are facing pressure for the second day in a row. Today's weakness comes in light of the weekly Energy Information Administration supply numbers. Last week, the agency found that stockpiles of the fuel increased by 40 billion cubic feet. Market analysts were hoping to see an uptick of 38 billion cubic feet.

SPDR S&P Biotech ETF

(XBI) - Get Report

-1.5%

The biotechnology industry is a noticeable drag today, as evidenced by the poor performance from XBI,

iShares Nasdaq Biotechnology Index Fund

(IBB) - Get Report

and

Biotech HOLDRs

(BBH) - Get Report

.

Industry leaders

Gilead

(GILD) - Get Report

and

Biogen

(BIIB) - Get Report

are taking some of the biggest hits from within this industry today, dipping around 2% each.

UltraShort 20+ Year Treasury Bond ProShares

(TBT) - Get Report

-1.1%

Long-term bonds are holding strong as investors face a choppy day of trading, pressuring TBT.

Investors should continue to use a cautious approach to playing these markets. Dividend-seeking ETFs such as the

iShares Dow Jones Select Dividend Index Fund

(DVY) - Get Report

provides investors with exposure to companies which pay out dividends. The yield from this fund will provide investors with some welcomed comfort in times of market volatility.

All prices as of 2:16 PM EST

-- Written by Don Dion in Williamstown, Mass.

At the time of publication, Dion Money Management was not long any of the equities mentioned.

Don Dion is president and founder of

Dion Money Management

, a fee-based investment advisory firm to affluent individuals, families and nonprofit organizations, where he is responsible for setting investment policy, creating custom portfolios and overseeing the performance of client accounts. Founded in 1996 and based in Williamstown, Mass., Dion Money Management manages assets for clients in 49 states and 11 countries. Dion is a licensed attorney in Massachusetts and Maine and has more than 25 years' experience working in the financial markets, having founded and run two publicly traded companies before establishing Dion Money Management.

Dion also is publisher of the Fidelity Independent Adviser family of newsletters, which provides to a broad range of investors his commentary on the financial markets, with a specific emphasis on mutual funds and exchange-traded funds. With more than 100,000 subscribers in the U.S. and 29 other countries, Fidelity Independent Adviser publishes six monthly newsletters and three weekly newsletters. Its flagship publication, Fidelity Independent Adviser, has been published monthly for 11 years and reaches 40,000 subscribers.